These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 26519551)
1. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
3. [Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma]. Pronina IV; Klimov EA; Burdennyy AM; Beresneva EV; Fridman MV; Ermilova VD; Kazubskaya TP; Karpukhin AV; Braga EA; Loginov VI Mol Biol (Mosk); 2017; 51(1):73-84. PubMed ID: 28251969 [TBL] [Abstract][Full Text] [Related]
4. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
5. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer]. Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes. Braga EA; Loginov VI; Pronina IV; Khodyrev DS; Rykov SV; Burdennyy AM; Friedman MV; Kazubskaya TP; Kubatiev AA; Kushlinskii NE Biochemistry (Mosc); 2015 Apr; 80(4):483-94. PubMed ID: 25869366 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228 [TBL] [Abstract][Full Text] [Related]
9. Methylation-associated silencing of Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818 [TBL] [Abstract][Full Text] [Related]
10. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132 [TBL] [Abstract][Full Text] [Related]
11. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis]. Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055 [TBL] [Abstract][Full Text] [Related]
12. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261 [TBL] [Abstract][Full Text] [Related]
15. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort. Cordero F; Ferrero G; Polidoro S; Fiorito G; Campanella G; Sacerdote C; Mattiello A; Masala G; Agnoli C; Frasca G; Panico S; Palli D; Krogh V; Tumino R; Vineis P; Naccarati A Carcinogenesis; 2015 Oct; 36(10):1144-53. PubMed ID: 26168820 [TBL] [Abstract][Full Text] [Related]
16. Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity. Pruikkonen S; Kallio MJ Br J Cancer; 2017 May; 116(11):1451-1461. PubMed ID: 28449010 [TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.]. Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]